DEXMEDETOMIDINA VERSUS PROPOFOL FOR SEDATION DURING ECOBRONCHOSCOPY

Phase 1

• Conditions: Patients with suspicion of malignant pulmonary neoplasia who need an ecobronchoscopy under sedation; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2015-001110-97-ES
• Lead Sponsor: Consorci Mar Parc de Salut de Barcelona

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-27
• Last Update Posted: 22 May 2017

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients under 18 years
Patients with suspicion of malignant pulmonary neoplasia who need an ecobronchoscopy under sedation
Patients with signed informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 35
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 35

Exclusion Criteria

Hypersensitivity to the active substance or to any of the included excipients
Advanced heart block (grade 2 or 3) unless paced.
Uncontrolled hypotension.
Acute cerebrovascular conditions.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified